Showing results (361-370 of 652) with videos related to

Sort By:
Pageof 66
Annals of Intensive Care|September 30, 2020
Early mechanical ventilation in patients with Guillain-Barré syndrome at high risk of respiratory failure: a randomized trialMarie-Anne Melone, Nicholas Heming, Paris Meng, et al.
The Lancet. Gastroenterology & Hepatology|January 14, 2023
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trialEdouard Louis, Matthieu Resche-Rigon, David Laharie, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Designing a Pediatric Study for an Antimalarial Drug by Using Information from AdultsCaroline Petit, Vincent Jullien, Adeline Samson, et al.
Statistical Methods in Medical Research|March 6, 2024
Bayesian framework for multi-source data integration-Application to human extrapolation from preclinical studiesSandrine Boulet, Moreno Ursino, Robin Michelet, et al.
Blood|April 4, 2002
Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantationHenrique Bittencourt, Vanderson Rocha, Sylvie Chevret, et al.
AIDS (London, England)|October 4, 2008
Restoration of Toxoplasma gondii-specific immune responses in patients with AIDS starting HAARTAndré Furco, Maryvonnick Carmagnat, Sylvie Chevret, et al.
Plos One|December 22, 2016
Dose-Finding Study of Omeprazole on Gastric pH in Neonates with Gastro-Esophageal Acid Reflux Using a Bayesian Sequential ApproachFlorentia Kaguelidou, Corinne Alberti, Valerie Biran, et al.
Biometrical Journal. Biometrische Zeitschrift|May 18, 2016
Determination of the optimal sample size for a clinical trial accounting for the population sizeNigel Stallard, Frank Miller, Simon Day, et al.
Emergency Medicine Journal : EMJ|March 27, 2019
Immune checkpoint blockade toxicity among patients with cancer presenting to the emergency departmentOlivier Peyrony, Yoann Tieghem, Jessica Franchitti, et al.
American Journal of Hematology|November 11, 2011
Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50-70-year old: a phase 1/2 study of the acute leukemia French associationHassan Farhat, Oumedaly Reman, Emmanuel Raffoux, et al.
Pageof 66